MedPath

EVALUATION of CATS TONOMETER PRISM in LASIK SUBJECTS

Completed
Conditions
Glaucoma
Normal Tension Glaucoma
Ocular Hypertension
Registration Number
NCT06266351
Lead Sponsor
Intuor Technologies, Inc.
Brief Summary

The CATS Tonometer prism clinical study is intended to determine repeatability of intraocular pressure measurement in human corneas which have undergone a LASIK procedure when compared to a standard Goldmann prism, validating the human LASIK eye findings comparing CATS Tonometer and Goldmann prisms to intracameral pressure in cadaver eyes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
198
Inclusion Criteria

Subjects must meet the following inclusion criteria to be eligible to participate in this clinical trial:

  • At least 22 years of age and undergone LASIK treatment
  • Subject has a clear understanding, English speakingand agrees to all the conditions of the informed consent form
Exclusion Criteria
  • Subjects will be excluded from participation if they meet the following criteria:

    • Subject has undergone ocular surgery within the last 3 months or LASIK within 6 months
    • Pregnant or nursing women
    • Those who have had previous corneal surgery excluding LASIK
    • Keratoconus
    • Corneal scarring
    • Microphthalmos
    • Buphthalmos
    • Dry eyes with clinical epithelial breakdown upon exam
    • Lid squeezers - blepharospasm
    • Nystagmus
    • Corneal or conjunctival infection.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IOP measurement difference between CATS and GAT in LASIK patientssingle measurement 1 day

IOP measurement

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Arizona Eye Consultants

🇺🇸

Tucson, Arizona, United States

Eye Specialty Group

🇺🇸

Memphis, Tennessee, United States

Arizona Eye Consultants
🇺🇸Tucson, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.